A new open-access journal, Biomedical Materials Science, has officially launched with its first editorial published on 22 January 2026, marking the debut of Volume 1 with the inaugural article in the series. The journal, published by Springer Nature, positions itself at the intersection of materials science, engineering, and clinical medicine, with a stated mission to provide a rigorous, interdisciplinary platform dedicated to the science, engineering, and application of biomedical materials in medicine and healthcare. The launch editorial, written by the Biomedical Materials Science Editorial Office, argues that the field has entered a transformative era in which innovation must be judged not only by scientific novelty but by its ability to address real clinical needs and improve patient outcomes.
The editorial frames the past decade as a period of rapid advances in materials design, nanotechnology, regenerative medicine, and bioprinting that have reshaped how scientists and clinicians approach diagnosis, treatment, tissue repair, and ultimately regeneration. According to the editorial, this growing sophistication has made one principle increasingly clear: the value of a new biomaterial cannot be measured by novelty alone. It is precisely at the intersection of scientific advancement and practical healthcare application, the editorial states, that the new journal finds its purpose. The publication welcomes high-quality research articles, reviews, and communications that drive innovation while ensuring that each material’s potential is understood through the lens of clinical relevance, translational feasibility, and biological performance.
At the core of the journal’s scope lie several key themes that reflect the breadth and evolving nature of the biomaterials field. The editors highlight the development, modification, and mechanistic understanding of materials designed for surgical implants, wound care, tissue repair, and a wide range of therapeutic interventions. Particular emphasis is placed on research that elucidates the molecular and cellular interactions between materials and biological systems, the interactions that govern biocompatibility, bioactivity, biosafety, mechanical performance, and ultimately the success or failure of a given material in vivo. By centering these mechanisms, the journal signals that it will prioritize studies explaining why materials behave as they do inside the body, rather than simply reporting that they do.
Equally central to the scope is the engineering and functionalization of advanced materials, including scaffolds, hydrogels, nanomaterials, smart surfaces, and multifunctional composites. The editorial notes that as the field pushes toward increasingly sophisticated structures and responsive materials, the journal is especially interested in work that not only introduces innovation in design but also demonstrates a clear path toward use in application. Studies that bridge the gap between bench and application, whether through mechanistic insight, robust biological evaluation, or translational models, are described as closely aligned with the journal’s vision. In the same line, the editors state that in vitro models of tissues and organs, healthy or diseased, comprising a material component are also considered, as tools to better understand physiological issues and to design and assess potential therapeutics.
A substantial portion of the launch statement is devoted to bioprinting and additive manufacturing, which the editorial describes as a transformative technology that has opened new horizons across regenerative medicine, personalized medicine, drug screening, cancer biology, and biohybrid device development. The journal welcomes submissions that explore these frontiers, particularly those that showcase the integration of biomaterials, living systems, and advanced fabrication strategies. The editors also point to the growing relevance of bio-based textiles, wearable technologies, and even implantable electronics, arguing that these developments show how materials science is expanding beyond traditional biomedical devices to embrace continuous monitoring, remote care, and patient-centered innovation.
Drug delivery receives its own dedicated section in the editorial, reflecting what the editors call the ever-expanding role of biomaterials in this domain. Materials are increasingly engineered to enhance therapeutic targeting, control release kinetics, and improve patient safety. Advances in nanoscale platforms, responsive materials, and hybrid systems are described as reshaping how drugs are delivered and how treatment outcomes can be optimized. The editorial states that such work is firmly within the journal’s scope and represents a crucial area of interest, alongside tissue engineering and regeneration, where biomaterials serve as the foundation for restoring structure and function to damaged tissues. Whether through scaffold innovation, cell-material interactions, or integrative regenerative strategies, these studies are said to embody the journal’s overarching goal of enabling materials-driven solutions that positively impact human health.
One of the more forward-looking sections of the editorial addresses the role of artificial intelligence in biomaterials research. According to the editors, AI is increasingly supporting innovation in the field by accelerating discovery and improving experimental precision. AI and machine-learning tools can predict material-cell interactions, optimize scaffold or nanomaterial design, analyze complex imaging data, and model biological performance more efficiently than traditional methods. These approaches are described as becoming especially valuable in areas such as bioprinting, drug delivery, regenerative medicine, and biosensing. The journal explicitly welcomes submissions that thoughtfully integrate AI or computational methods to enhance mechanistic insight, strengthen biological evaluation, or improve translational potential, and the editors predict that AI’s role in materials science will be central to advancing technologies that meaningfully impact patient care.
Alongside its enthusiasm for AI, the editorial sets out clear boundaries grounded in Springer Nature’s policy on AI use, which emphasizes transparency, accountability, and research integrity. Large language models such as ChatGPT cannot be listed as authors, and any use of AI to support content generation must be documented in the manuscript, except for routine AI-assisted copyediting. AI-generated images are generally not permitted due to unresolved legal and ethical issues, with only narrowly defined exceptions allowed and clearly labeled. Non-generative AI tools used to enhance existing images must be disclosed. The policy also extends to peer review: reviewers should not upload manuscripts into generative AI tools, given concerns around accuracy, confidentiality, and data security, and any AI assistance used to support their assessment must be declared in the review. These provisions signal that the journal intends to embrace computational innovation while holding submissions to strict standards of disclosure.
Beyond its technical scope, the launch editorial extends an open invitation to the research community. As an open and collaborative platform, Biomedical Materials Science welcomes contributions from researchers, clinicians, engineers, and industry partners, and encourages interdisciplinary submissions that reflect the complexity of today’s challenges and the multifaceted solutions required to address them. The stated goal is to foster a scientific community where ideas can be exchanged freely and where high-quality work can meaningfully influence the future of patient care. The editors close by inviting readers to join the endeavor through submitting research, engaging in review, and proposing thematic collections, expressing excitement about launching the journal at a time when biomaterials science is poised to shape the next generation of medical technologies. The inaugural article is fully open access, and the journal’s first volume is now live with the launch editorial as its opening contribution.
Subject of Research: Launch of the open-access journal Biomedical Materials Science and the scope of its inaugural editorial
Article Title: Introducing Biomedical Materials Science: advancing materials innovation for real-world healthcare impact
Article References: Biomedical Materials Science Editorial Office (2026). Introducing Biomedical Materials Science: advancing materials innovation for real-world healthcare impact. Biomedical Materials Science, 1(1), Article 1. https://doi.org/10.1186/s44495-025-00003-w
Image Credits: AI Generated
DOI: 10.1186/s44495-025-00003-w
Keywords: biomedical materials science, biomaterials, Springer Nature, journal launch, tissue engineering, drug delivery, bioprinting, nanomaterials, scaffolds, regenerative medicine, artificial intelligence, open access
